Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$22.17 - $51.8 $108,633 - $253,820
4,900 New
4,900 $252,000
Q1 2022

May 13, 2022

BUY
$22.22 - $39.12 $2.28 Million - $4.01 Million
102,589 Added 377.17%
129,789 $3.25 Million
Q4 2021

Feb 11, 2022

SELL
$18.38 - $40.5 $3.41 Million - $7.51 Million
-185,482 Reduced 87.21%
27,200 $990,000
Q3 2021

Nov 12, 2021

BUY
$13.18 - $19.83 $2.65 Million - $3.99 Million
201,082 Added 1733.47%
212,682 $3.64 Million
Q1 2021

May 17, 2021

BUY
$49.53 - $68.4 $574,548 - $793,440
11,600 New
11,600 $594,000
Q4 2020

Feb 16, 2021

SELL
$47.25 - $65.16 $4.02 Million - $5.54 Million
-85,000 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$46.35 - $61.69 $2.22 Million - $2.95 Million
-47,797 Reduced 35.99%
85,000 $4.66 Million
Q2 2020

Aug 14, 2020

SELL
$38.58 - $65.07 $2.34 Million - $3.95 Million
-60,703 Reduced 31.37%
132,797 $7.64 Million
Q1 2020

May 15, 2020

BUY
$32.73 - $50.78 $2.52 Million - $3.92 Million
77,099 Added 66.24%
193,500 $7.78 Million
Q4 2019

Feb 13, 2020

BUY
$6.81 - $39.55 $350,040 - $2.03 Million
51,401 Added 79.08%
116,401 $4.6 Million
Q3 2019

Nov 14, 2019

BUY
$6.47 - $8.96 $349,380 - $483,840
54,000 Added 490.91%
65,000 $440,000
Q2 2019

Aug 13, 2019

BUY
$8.31 - $14.85 $91,410 - $163,350
11,000 New
11,000 $102,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.